About Remix Therapeutics
Remix Therapeutics is a private company based in Watertown, Massachusetts, incorporated in 2019 in Delaware. It has reported $13,740,355 raised in one offering on Form D since January 2024. Its chief executive is Peter Smith.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Dec 22, 2023 | Jan 4, 2024 | $13,740,355of $90.0M target | 21 | $654K | Debt, OptionsRule 506(b) | Form D ↗ |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Remix Therapeutics's Form D filed Jan 4, 2024.
PS
Peter Smith
President & CEO, director
RG
Robert Gagnon
Executive officer
MP
Matthew Patterson
Director
KB
Kevin Bitterman
Director
JG
Jeff Goater
Director
MR
Michael Rome
Director
SB
Scott Biller
Director
HW
Heather Wasserman
Executive officer